Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.
Discover more about S&P Global’s offerings
Synlogic names COO
Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.